ST
CRDF icon

Spot Trading’s Cardiff Oncology CRDF Stock Holding History

Spot Trading’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-92
Closed -$30K – 3130
2016
Q2 		$30K Buy
+92
New +$31.7K ﹤0.01% 2903
2015
Q4 		– Sell
-251
Closed -$103K – 3679
2015
Q3 		$103K Hold
251
– – ﹤0.01% 3035
2015
Q2 		$184K Buy
+251
New +$178K ﹤0.01% 2759

Other funds holding CRDF

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MWVC
Morgens Waterfall Vintiadis & Co New York $81.2M AUM 86.87% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Spot Trading's CRDF Position: Q3 2016 in Review

Spot Trading sold out of Cardiff Oncology (CRDF) in Q3 2016, closing a stake of 95 shares — an estimated $31K sold.

Spot Trading first reported a position in CRDF in Q2 2016 and held it in 1 quarter. The position peaked at $31K in Q2 2016. 66 funds tracked by Wall St. Rank hold CRDF as of Q3 2016.

  • Spot Trading reported no remaining Cardiff Oncology position as of Q3 2016 after selling out during the quarter.
  • Spot Trading sold 95 Cardiff Oncology shares in Q3 2016, an estimated $31K.
  • Spot Trading first reported a position in Cardiff Oncology in Q2 2016 and held it in 1 quarter.
  • Spot Trading's Cardiff Oncology position peaked at $31K in Q2 2016.
  • 66 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2016.

Based on Spot Trading's 13F filing for Q3 2016, filed 31 Oct 2016.